The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion

Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aman Upadhyay, Kate E. Boyle, Tom L. Broderick
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/aadbde9767c846b08b8b2a0e8cf5e801
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aadbde9767c846b08b8b2a0e8cf5e801
record_format dspace
spelling oai:doaj.org-article:aadbde9767c846b08b8b2a0e8cf5e8012021-11-25T18:27:59ZThe Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion10.3390/molecules262268721420-3049https://doaj.org/article/aadbde9767c846b08b8b2a0e8cf5e8012021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/22/6872https://doaj.org/toc/1420-3049Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequences of type 1 diabetes, including hypoinsulinemia, hyperglycemia, and increased urine output. Systemic hypocarnitinemia, expressed as free carnitine levels, was evident in the plasma, liver, and kidney of diabetic rats. Compared to control rats, the low free carnitine in the plasma of diabetic rats was accompanied by decreased expression of γ-butyrobetaine hydroxylase in liver and kidney, suggesting impaired carnitine biosynthesis. Expression of organic cation transporter-2 in kidney was also reduced, indicating impaired renal reabsorption, and confirmed by the presence of elevated levels of free carnitine in the urine of diabetic rats. Insulin treatment of diabetic rats reversed the plasma hypocarnitinemia, increased the free carnitine content in both kidney and liver, and prevented urinary losses of free carnitine. This was associated with increased expression of γ-butyrobetaine hydroxylase and organic cation transporter-2. The results of our study indicate that type 1 diabetes induced with streptozotocin disrupts carnitine biosynthesis and renal uptake mechanisms, leading to carnitine insufficiency. These aberrations in carnitine homeostasis are prevented with daily insulin treatment.Aman UpadhyayKate E. BoyleTom L. BroderickMDPI AGarticlediabetescarnitinebiosynthesisuptakekidneyurineOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6872, p 6872 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetes
carnitine
biosynthesis
uptake
kidney
urine
Organic chemistry
QD241-441
spellingShingle diabetes
carnitine
biosynthesis
uptake
kidney
urine
Organic chemistry
QD241-441
Aman Upadhyay
Kate E. Boyle
Tom L. Broderick
The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
description Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequences of type 1 diabetes, including hypoinsulinemia, hyperglycemia, and increased urine output. Systemic hypocarnitinemia, expressed as free carnitine levels, was evident in the plasma, liver, and kidney of diabetic rats. Compared to control rats, the low free carnitine in the plasma of diabetic rats was accompanied by decreased expression of γ-butyrobetaine hydroxylase in liver and kidney, suggesting impaired carnitine biosynthesis. Expression of organic cation transporter-2 in kidney was also reduced, indicating impaired renal reabsorption, and confirmed by the presence of elevated levels of free carnitine in the urine of diabetic rats. Insulin treatment of diabetic rats reversed the plasma hypocarnitinemia, increased the free carnitine content in both kidney and liver, and prevented urinary losses of free carnitine. This was associated with increased expression of γ-butyrobetaine hydroxylase and organic cation transporter-2. The results of our study indicate that type 1 diabetes induced with streptozotocin disrupts carnitine biosynthesis and renal uptake mechanisms, leading to carnitine insufficiency. These aberrations in carnitine homeostasis are prevented with daily insulin treatment.
format article
author Aman Upadhyay
Kate E. Boyle
Tom L. Broderick
author_facet Aman Upadhyay
Kate E. Boyle
Tom L. Broderick
author_sort Aman Upadhyay
title The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_short The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_full The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_fullStr The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_full_unstemmed The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_sort effects of streptozotocin-induced diabetes and insulin treatment on carnitine biosynthesis and renal excretion
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/aadbde9767c846b08b8b2a0e8cf5e801
work_keys_str_mv AT amanupadhyay theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT kateeboyle theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT tomlbroderick theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT amanupadhyay effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT kateeboyle effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT tomlbroderick effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
_version_ 1718411151255011328